317 related articles for article (PubMed ID: 29282520)
1. TGFβ counteracts LYVE-1-mediated induction of lymphangiogenesis by small hyaluronan oligosaccharides.
Bauer J; Rothley M; Schmaus A; Quagliata L; Ehret M; Biskup M; Orian-Rousseau V; Jackson DG; Pettis RJ; Harvey A; Bräse S; Thiele W; Sleeman JP
J Mol Med (Berl); 2018 Feb; 96(2):199-209. PubMed ID: 29282520
[TBL] [Abstract][Full Text] [Related]
2. FK506 induces lung lymphatic endothelial cell senescence and downregulates LYVE-1 expression, with associated decreased hyaluronan uptake.
Shrestha S; Cho W; Stump B; Imani J; Lamattina AM; Louis PH; Pazzanese J; Rosas IO; Visner G; Perrella MA; El-Chemaly S
Mol Med; 2020 Jul; 26(1):75. PubMed ID: 32736525
[TBL] [Abstract][Full Text] [Related]
3. Low molecular weight hyaluronan induces lymphangiogenesis through LYVE-1-mediated signaling pathways.
Wu M; Du Y; Liu Y; He Y; Yang C; Wang W; Gao F
PLoS One; 2014; 9(3):e92857. PubMed ID: 24667755
[TBL] [Abstract][Full Text] [Related]
4. The cooperative role of S1P3 with LYVE-1 in LMW-HA-induced lymphangiogenesis.
Yu M; Zhang H; Liu Y; He Y; Yang C; Du Y; Wu M; Zhang G; Gao F
Exp Cell Res; 2015 Aug; 336(1):150-7. PubMed ID: 26116468
[TBL] [Abstract][Full Text] [Related]
5. In vitro assays using primary embryonic mouse lymphatic endothelial cells uncover key roles for FGFR1 signalling in lymphangiogenesis.
Kazenwadel J; Secker GA; Betterman KL; Harvey NL
PLoS One; 2012; 7(7):e40497. PubMed ID: 22792354
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan-induced VEGF-C promotes fibrosis-induced lymphangiogenesis via Toll-like receptor 4-dependent signal pathway.
Jung YJ; Lee AS; Nguyen-Thanh T; Kang KP; Lee S; Jang KY; Kim MK; Kim SH; Park SK; Kim W
Biochem Biophys Res Commun; 2015 Oct; 466(3):339-45. PubMed ID: 26362177
[TBL] [Abstract][Full Text] [Related]
7. Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1.
Johnson LA; Prevo R; Clasper S; Jackson DG
J Biol Chem; 2007 Nov; 282(46):33671-33680. PubMed ID: 17884820
[TBL] [Abstract][Full Text] [Related]
8. SIX1 promotes tumor lymphangiogenesis by coordinating TGFβ signals that increase expression of VEGF-C.
Liu D; Li L; Zhang XX; Wan DY; Xi BX; Hu Z; Ding WC; Zhu D; Wang XL; Wang W; Feng ZH; Wang H; Ma D; Gao QL
Cancer Res; 2014 Oct; 74(19):5597-607. PubMed ID: 25142796
[TBL] [Abstract][Full Text] [Related]
9. TGFβ signaling is required for sprouting lymphangiogenesis during lymphatic network development in the skin.
James JM; Nalbandian A; Mukouyama YS
Development; 2013 Sep; 140(18):3903-14. PubMed ID: 23946447
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib.
Lin T; Gong L
Drug Des Devel Ther; 2017; 11():1147-1158. PubMed ID: 28435226
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronan in the lymphatics: The key role of the hyaluronan receptor LYVE-1 in leucocyte trafficking.
Jackson DG
Matrix Biol; 2019 May; 78-79():219-235. PubMed ID: 29425695
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the interaction of fibroblast growth factor-2 with the lymphatic endothelial cell marker LYVE-1.
Platonova N; Miquel G; Regenfuss B; Taouji S; Cursiefen C; Chevet E; Bikfalvi A
Blood; 2013 Feb; 121(7):1229-37. PubMed ID: 23264596
[TBL] [Abstract][Full Text] [Related]
13. Binding of Hyaluronan to the Native Lymphatic Vessel Endothelial Receptor LYVE-1 Is Critically Dependent on Receptor Clustering and Hyaluronan Organization.
Lawrance W; Banerji S; Day AJ; Bhattacharjee S; Jackson DG
J Biol Chem; 2016 Apr; 291(15):8014-30. PubMed ID: 26823460
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of small hyaluronan oligosaccharides in tumour interstitial fluid correlates with lymphatic invasion and lymph node metastasis.
Schmaus A; Klusmeier S; Rothley M; Dimmler A; Sipos B; Faller G; Thiele W; Allgayer H; Hohenberger P; Post S; Sleeman JP
Br J Cancer; 2014 Jul; 111(3):559-67. PubMed ID: 24937668
[TBL] [Abstract][Full Text] [Related]
15. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
[TBL] [Abstract][Full Text] [Related]
16. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium.
Prevo R; Banerji S; Ferguson DJ; Clasper S; Jackson DG
J Biol Chem; 2001 Jun; 276(22):19420-30. PubMed ID: 11278811
[TBL] [Abstract][Full Text] [Related]
17. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
[TBL] [Abstract][Full Text] [Related]
18. The β
Kumaravel S; Abbey CA; Bayless KJ; Chakraborty S
Am J Physiol Cell Physiol; 2020 Dec; 319(6):C1045-C1058. PubMed ID: 33052069
[TBL] [Abstract][Full Text] [Related]
19. The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells.
Al-Rawi MA; Watkins G; Mansel RE; Jiang WG
Int J Oncol; 2005 Sep; 27(3):721-30. PubMed ID: 16077922
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
